Phaarmasia - Quaterly Results

09 Nov 2021 Evaluate
The company witnessed a 18.50% growth in the revenue at Rs. 52.90 millions for the quarter ended September 2021 as compared to Rs. 44.64 millions during the year-ago period.The Net Loss for the quarter ended September 2021 is Rs. -7.10 millions as compared to Net Profit of Rs. 0.83 millions of corresponding quarter ended September 2020Operating profit Margin for the quarter ended September 2021 slipped to -6.48% as compared to 1.92% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 52.90 44.64 18.50 91.80 97.15 -5.51 198.95 244.54 -18.64
Other Income 1.59 0.83 91.57 2.34 1.54 51.95 8.94 5.78 54.67
PBIDT -6.48 1.92 -437.50 -5.20 3.52 -247.73 8.32 13.97 -40.44
Interest 0.01 0.03 -66.67 0.02 0.05 -60.00 0.12 0.37 -67.57
PBDT -6.49 1.89 -443.39 -5.22 3.47 -250.43 8.20 13.60 -39.71
Depreciation 0.74 0.86 -13.95 1.47 1.71 -14.04 3.42 3.99 -14.29
PBT -7.23 1.03 -801.94 -6.69 1.76 -480.11 4.78 9.61 -50.26
TAX -0.13 0.20 -165.00 0.00 0.39 -100.00 1.67 4.21 -60.33
Deferred Tax 0.04 -0.05 -180.00 0.00 -0.09 -100.00 -0.18 1.55 -111.61
PAT -7.10 0.83 -955.42 -6.69 1.37 -588.32 3.11 5.40 -42.41
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) -12.25 4.30 -384.80 -5.66 3.62 -256.34 4.18 5.71 -26.80

Phaarmasia Share Price

106.25 -2.16 (-1.99%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×